Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer
出版年份 2022 全文链接
标题
Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer
作者
关键词
-
出版物
BMC Medicine
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-10
DOI
10.1186/s12916-022-02362-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Alternative Splicing as Adjunctive Treatment in EML4-ALK v3a/b+ NSCLC: Knowing Our Socratic Paradox and Learning From Spinal Muscular Atrophy
- (2022) Misako Nagasaka et al. Journal of Thoracic Oncology
- Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive Disease
- (2022) Sai-Hong I. Ou et al. Journal of Thoracic Oncology
- Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
- (2021) Justin F Gainor et al. LANCET ONCOLOGY
- Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing
- (2020) Danielle Cohen et al. Journal of Thoracic Oncology
- Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in non-small cell lung cancer
- (2020) Weihua Li et al. Journal of Thoracic Oncology
- Emerging therapeutic agents for advanced non-small cell lung cancer
- (2020) Ruqin Chen et al. Journal of Hematology & Oncology
- Roles and mechanisms of alternative splicing in cancer — implications for care
- (2020) Sophie C. Bonnal et al. Nature Reviews Clinical Oncology
- Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome
- (2020) Sara Cherry et al. GENES & DEVELOPMENT
- Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC
- (2020) Weihua Li et al. Journal of Thoracic Oncology
- TRK inhibitors in TRK fusion-positive cancers
- (2019) A Drilon ANNALS OF ONCOLOGY
- Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples
- (2018) Kurtis D. Davies et al. Journal of Thoracic Oncology
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. Journal of Thoracic Oncology
- Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer
- (2018) Jason N Rosenbaum et al. MODERN PATHOLOGY
- Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions
- (2018) Weihua Li et al. Molecular Oncology
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
- (2018) Qingsong Gao et al. Cell Reports
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- Detection of known and novel FGFR fusions in non-small cell lung cancer by comprehensive genomic profiling
- (2018) Angel Qin et al. Journal of Thoracic Oncology
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line
- (2014) Tatsushi Kodama et al. Journal of Thoracic Oncology
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
- (2013) J. Ying et al. ANNALS OF ONCOLOGY
- Fusion genes and their discovery using high throughput sequencing
- (2013) M.J. Annala et al. CANCER LETTERS
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
- (2012) H. Thorvaldsdottir et al. BRIEFINGS IN BIOINFORMATICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started